(1)
Bevacizumab in Combination With FOLFIRI in the First-Line Treatment of Patients With Advanced Colorectal Cancer: A Single-Institution Experience. J. Anal. Oncol. 2014, 3 (1),  26-32. https://doi.org/10.6000/1927-7229.2014.03.01.4.